Sildenafil
Product Images NDC 50436-0710

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 50436-0710). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unit Dose Services, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Camberlogo1 (Camberlogo1)

FDA Label Image

Camberlogo2 (Camberlogo2)

FDA Label Image

Sildenafilfigure7 (Sildenafilfigure7)

Sildenafilfigure7 (Sildenafilfigure7)
A bar graph illustrating the percentage of patients reporting improvement across four treatment groups: Placebo (24%), Sildenafil Citrate Tablets 25 mg (63%), 50 mg (74%), and 100 mg (82%). The x-axis lists treatment groups with patient counts; the y-axis shows percentage improvement from 0% to 100%.*
FDA Label Image

Label Image (Lbl504360710)

Label Image (Lbl504360710)
Sildenafil 50 mg Unit Dose Services packaging label showing a unit dose pouch containing one film-coated tablet of sildenafil citrate equivalent to 50 mg sildenafil. The label includes storage instructions, manufacturer and repackager information, an NDC barcode, and contact details for questions or comments.*
FDA Label Image

Lbl504360711

Lbl504360711
Sildenafil 100 mg unit dose pouch label by Unit Dose Services, for prescription use only. Each foil-coated tablet contains sildenafil citrate equivalent to 100 mg sildenafil. Packaging is one tablet per pouch, with 1,080 pouches per case. The label includes storage instructions, manufacturer and repackager information, lot number, expiration date fields, and a barcode.*
FDA Label Image

Sildenafilfigure1 (Sildenafilfigure1)

Sildenafilfigure1 (Sildenafilfigure1)
A line chart comparing systolic blood pressure (mmHg) over time post dose (hours) for Sildenafil 100 mg versus placebo. The x-axis shows time from pre-dose to 24 hours, and the y-axis measures changes in systolic blood pressure. Two lines represent the effects of Sildenafil and placebo treatments over the 24-hour period.*
FDA Label Image

Sildenafilfigure2 (Sildenafilfigure2)

Sildenafilfigure2 (Sildenafilfigure2)
A line graph depicting change in blood pressure over time in hours postdose, comparing two treatments: Docasalin + Placebo and Docasalin + Cialis (Sildenafil) 25 mg. The y-axis represents change in blood pressure (mmHg), while the x-axis shows time postdose in hours. Data points for each treatment are differentiated by color and shape.*
FDA Label Image

Sildenafilfigure3 (Sildenafilfigure3)

Sildenafilfigure3 (Sildenafilfigure3)
A line graph depicting the change in a variable labeled as FSE (x10 6 cells) over time postdose in hours. It compares two conditions: Doxorubicin + Placebo (blue line with dots) and Doxorubicin + Sildenafil 50 mg (black line with dots). The graph shows fluctuations in the variable values from 0 to 8 hours.*
FDA Label Image

Sildenafilfigure4 (Sildenafilfigure4)

Sildenafilfigure4 (Sildenafilfigure4)
A line graph comparing the effect of doxazosin combined with sildenafil 100 mg versus doxazosin combined with placebo on a variable measured in mmHg. The x-axis represents time after dosing in hours, and the y-axis represents the change in mmHg. The graph shows data points and trend lines for both treatment groups over an 8-hour period.*
FDA Label Image

Sildenafilfigure5 (Sildenafilfigure5)

Sildenafilfigure5 (Sildenafilfigure5)
A line graph showing plasma concentration (ng/mL) over time (hours) after a single dose of Sildenafil commercial tablet. The curve rises sharply to a peak concentration before gradually declining over 24 hours.*
FDA Label Image

Sildenafilfigure6a (Sildenafilfigure6a)

Sildenafilfigure6a (Sildenafilfigure6a)
A bar chart showing percentage of patients at endpoint across different baseline scores (0 to 5). Multiple bars per baseline score represent varying categories numbered 0 to 5 in the legend. Percentages range from 0 to 80% on the vertical axis, illustrating distribution differences by baseline score and category.*
FDA Label Image

Sildenafilfigure6b (Sildenafilfigure6b)

Sildenafilfigure6b (Sildenafilfigure6b)
A bar chart depicting the percentage of patients at endpoint according to their baseline score categories (0 to 5). Each baseline score group has multiple bars representing different categories labeled 00 to 05, indicating distribution percentages within each baseline score.*
FDA Label Image

Sildenafilheterologo1 (Sildenafilheterologo1)

FDA Label Image

Sildenafilheterologo2 (Sildenafilheterologo2)

Sildenafilheterologo2 (Sildenafilheterologo2)
The image shows a blister card of Sildenafil tablets by Unit Dose Services. The card is white with black text, featuring the brand name 'HETERO' in bold. Two round tablets are visible, each placed in separate cavities of the blister pack with perforated tabs above each tablet for easy dispensing.*
FDA Label Image

Sildenafilstructure (Sildenafilstructure)

Sildenafilstructure (Sildenafilstructure)
Chemical structure diagram showing the molecular composition of Sildenafil, including its characteristic ring systems and functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.